SEC Form 4/A · accession 0001610717-26-000335
Omada Health, Inc. · OMDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Sean P. Duffy
Officer — Chief Executive Officer · Director
Period of report
Jun 24, 2026
Accepted (ET)
Jul 8, 2026 · 8:22 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001611115
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 24, 2026 | M | 2,800 | $5.82 | A | 414,661 | D | |
| Common StockF3,F1 | Jun 24, 2026 | S | 2,800 | $19.0139 | D | 411,861 | D | |
| Common Stock | Jun 25, 2026 | M | 300 | $5.82 | A | 412,161 | D | |
| Common StockF4,F1 | Jun 25, 2026 | S | 300 | $19.0033 | D | 411,861 | D | |
| Common Stock | Jun 26, 2026 | M | 9,844 | $5.82 | A | 421,705 | D | |
| Common StockF1 | Jun 26, 2026 | S | 9,844 | $19.6072 | D | 411,861 | D | |
| Common Stock | Jun 26, 2026 | M | 4,314 | $8.28 | A | 416,175 | D | |
| Common StockF1 | Jun 26, 2026 | S | 4,314 | $20.90 | D | 411,861 | D | |
| Common StockF5 | holding | — | — | — | 851,659 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F6 | $5.82 | Jun 24, 2026 | M | 2,800 | D | — | Aug 21, 2029 | Common Stock | 2,800 | 178,515 | D |
| Stock Option (Right to Buy)F6 | $5.82 | Jun 25, 2026 | M | 300 | D | — | Aug 21, 2029 | Common Stock | 300 | 178,215 | D |
| Stock Option (Right to Buy)F6 | $5.82 | Jun 26, 2026 | M | 9,844 | D | — | Aug 21, 2029 | Common Stock | 9,844 | 168,371 | D |
| Stock Option (Right to Buy)F6 | $8.28 | Jun 26, 2026 | M | 4,314 | D | — | May 5, 2031 | Common Stock | 4,314 | 129,019 | D |
Explanation of responses
- F1This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
- F2Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- F3This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $19.00 to $19.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
- F6100% of the shares subject to the option are fully vested and exercisable